Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
shareholder lawsuit
Pharma
Syntimmune shareholders win again over AZ, this time for $181M
A Delaware judge has sided with Syntimmune shareholders over AstraZeneca, granting a $181 million award on top of a $130 million decision last year.
Kevin Dunleavy
Jun 12, 2025 11:40am
With investor lawsuit and trial flop, troubles mount for Marinus
Jun 17, 2024 4:33pm
It had to happen: Ex-Celgene shareholders sue BMS for $6B
Jun 3, 2021 5:04pm
Reluctant Spark investors force Roche to extend $4.3B offer
Apr 3, 2019 11:27am
AbbVie faces investor ire in wake of Humira kickback suit
Oct 11, 2018 11:24am
Allergan targeted in investor suit over alleged price fixing
Nov 7, 2017 9:12am
